Search research articles
Contact Us
Filters
Showing results (371-380 of 488) with videos related to
Page
of 49
Sort By:
American Journal of Hematology
|
May 14, 2022
Timing of response with venetoclax combination treatment in patients with newly diagnosed acute myeloid leukemia
Brian A Jonas, Andrew H Wei, Christian Recher, et al.
The Journal of Allergy and Clinical Immunology
|
November 13, 2012
Reduced type I interferon production by dendritic cells and weakened antiviral immunity in patients with Wiskott-Aldrich syndrome protein deficiency
Philipp A Lang, Namir Shaabani, Stephanie Borkens, et al.
Cancer
|
April 8, 2015
Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group
Thorsten Braun, Sophie Cereja, Sylvie Chevret, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
August 18, 2015
Virus-Induced Type I Interferon Deteriorates Control of Systemic Pseudomonas Aeruginosa Infection
Katja Merches, Vishal Khairnar, Torben Knuschke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 28, 2005
Early allogeneic stem-cell transplantation for young adults with acute myeloblastic leukemia in first complete remission: an intent-to-treat long-term analysis of the BGMT experience
Eric Jourdan, Jean-Michel Boiron, Nicole Dastugue, et al.
Conservation Biology : the Journal of the Society for Conservation Biology
|
July 25, 2009
Major conservation policy issues for biodiversity in Oceania
R T Kingsford, J E M Watson, C J Lundquist, et al.
The New England Journal of Medicine
|
September 15, 2007
High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis
Arnaud Jaccard, Philippe Moreau, Veronique Leblond, et al.
Haematologica
|
February 13, 2023
Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy
Thomas Pabst, Norbert Vey, Lionel Adès, et al.
Leukemia & Lymphoma
|
November 28, 2024
Azacitidine and venetoclax with or without pevonedistat in patients with newly diagnosed acute myeloid leukemia
Nicholas J Short, Agnieszka Wierzbowska, Thomas Cluzeau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2009
Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup
Thomas Prébet, Nicolas Boissel, Sarah Reutenauer, et al.
Page
of 49
Search research articles
Search
Showing results (371-380 of 488) with videos related to
Sort By:
Page
of 49
American Journal of Hematology
|
May 14, 2022
Timing of response with venetoclax combination treatment in patients with newly diagnosed acute myeloid leukemia
Brian A Jonas, Andrew H Wei, Christian Recher, et al.
The Journal of Allergy and Clinical Immunology
|
November 13, 2012
Reduced type I interferon production by dendritic cells and weakened antiviral immunity in patients with Wiskott-Aldrich syndrome protein deficiency
Philipp A Lang, Namir Shaabani, Stephanie Borkens, et al.
Cancer
|
April 8, 2015
Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group
Thorsten Braun, Sophie Cereja, Sylvie Chevret, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
August 18, 2015
Virus-Induced Type I Interferon Deteriorates Control of Systemic Pseudomonas Aeruginosa Infection
Katja Merches, Vishal Khairnar, Torben Knuschke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 28, 2005
Early allogeneic stem-cell transplantation for young adults with acute myeloblastic leukemia in first complete remission: an intent-to-treat long-term analysis of the BGMT experience
Eric Jourdan, Jean-Michel Boiron, Nicole Dastugue, et al.
Conservation Biology : the Journal of the Society for Conservation Biology
|
July 25, 2009
Major conservation policy issues for biodiversity in Oceania
R T Kingsford, J E M Watson, C J Lundquist, et al.
The New England Journal of Medicine
|
September 15, 2007
High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis
Arnaud Jaccard, Philippe Moreau, Veronique Leblond, et al.
Haematologica
|
February 13, 2023
Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy
Thomas Pabst, Norbert Vey, Lionel Adès, et al.
Leukemia & Lymphoma
|
November 28, 2024
Azacitidine and venetoclax with or without pevonedistat in patients with newly diagnosed acute myeloid leukemia
Nicholas J Short, Agnieszka Wierzbowska, Thomas Cluzeau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2009
Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup
Thomas Prébet, Nicolas Boissel, Sarah Reutenauer, et al.
Page
of 49